RenovoRx Inc.

NASDAQ:RNXT

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

The Conversation (0)
MARKETS
COMMODITIES
CURRENCIES